Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Aug;37(8):1610-1611.
doi: 10.1002/mds.29137. Epub 2022 Jun 29.

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene

Jose L Labandeira-Garcia  1 , Juan A Parga  1
Affiliations
Comment

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene

Jose L Labandeira-Garcia et al. Mov Disord. 2022 Aug.

Abstract

© 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

PubMed Disclaimer

Comment on

References

    1. Kamath T, Abdulraouf A, Burris SJ, et al. Single‐cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease. Nat Neurosci 2022;25(5):588–595. - PMC - PubMed
    1. Rodriguez‐Perez AI, Sucunza D, et al. Angiotensin type 1 receptor antagonists protect against alpha‐Synuclein‐induced Neuroinflammation and dopaminergic neuron death. Neurotherapeutics 2018;15(4):1063–1081. - PMC - PubMed
    1. Kim G‐HJ, Mo H, Liu H, et al. A zebrafish screen reveals renin‐angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons. Elife 2021;10:e69795. - PMC - PubMed
    1. Labandeira‐Garcia JL, Valenzuela R, et al. The intracellular renin‐angiotensin system: friend or foe. Some light from the dopaminergic neurons. Prog Neurobiol 2021;199:101919. - PMC - PubMed
    1. Jo Y, Kim S, et al. Protective effect of renin‐angiotensin system inhibitors on Parkinson's disease: a nationwide cohort study. Front Pharmacol 2022;13:837890. - PMC - PubMed

Publication types